General form of registration statement for all companies including face-amount certificate companies

CONSOLIDATED STATEMENTS OF CASH FLOWS

v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
 9 Months Ended 12 Months Ended
Jul. 31, 2014
Jul. 31, 2013
Oct. 31, 2013
Oct. 31, 2012
Cash flows from operating activities:        
Payments to suppliers, employees and consultants       $ (3,401,499) $ (3,164,613)
Cash received from patent monetization and patent assertion       213,850 7,075
Dividends and interest received       851 16,790
Net cash used in operating activities (2,017,179) (2,642,399) (3,186,798) (3,140,748)
Cash flows from investing activities:        
Disbursements to acquire short-term investments in certificates of deposit (3,700,000)    (250,000) (1,200,000)
Proceeds from sales of short-term investments in certificates of deposit 1,150,000 500,000 750,000 2,948,551
Other (3,798) (676) (676) (600)
Net cash provided by investing activities (2,553,798) 499,324 499,324 1,747,951
Cash flows from financing activities:        
Proceeds from issuance of convertible debentures 3,500,000 1,765,000 1,765,000 750,000
Proceeds from sale of common stock 3,673,135 589,865 1,050,405   
Proceeds from exercise of warrants to purchase common stock 300,009 380,800 380,800   
Proceeds from exercise of employee stock options 51,225 25,610 25,610 208,450
Payments to redeem convertible debentures (200,000)         
Net cash provided by financing activities 7,324,369 2,785,413 3,245,953 958,450
Net increase (decrease) in cash and cash equivalents 2,753,392 642,338 558,479 (434,347)
Cash and cash equivalents at beginning of year 898,172 339,693 339,693 774,040
Cash and cash equivalents at end of year 3,651,564 982,031 898,172 339,693
Reconciliation of net loss to net cash used in operating activities:        
Net loss (6,452,870) (7,153,332) (10,080,086) (4,252,799)
Stock option compensation to employees 1,562,350 2,118,424 2,693,121 614,914
Stock option compensation to consultants 784,237 574,374 1,105,018 110,351
Common stock issued to employees pursuant to stock incentive plans          927,356
Common stock issued to consultants 40,748 168,475 304,685 75,932
Common stock issued to acquire patent license 62,000 42,000 42,000   
Common stock issued to pay interest on convertible debentures 61,778 69,939 98,739   
Change in value of derivative liability 1,460,704 (315,189) (475,189)   
Loss on extinguishment of debt 482,915 343,517 343,517   
Amortization of patents 233,129 0 0 0
Amortized interest on patent acquisition obligations to interest expense 286,002      
Amortization of convertible debenture discount to interest expense 575,210 893,149 991,180   
Impairment in value of investment in Videocon Industries Limited GDR’s       1,184,710   
Impairment in value of investment in Volga-Svet Ltd.          127,500
Other (553) 35,490 9,753 7,956
Change in operating assets and liabilities:        
Accounts receivable 41,667    (175,000)   
Prepaid expenses and other current assets 60,066 8,574 (78,320) 13,382
Accounts payable and accrued expenses 28,101 572,180 641,331 174,670
Royalties and contingent legal fees payable (55,343)    207,743   
Deferred revenue (1,187,320)       (940,010)
Supplemental disclosure of non-cash financing activities:        
Non-cash patent acquisition 3,036,111       
Common stock to acquire patent license 247,600 42,000 42,000  
Common stock issued upon conversion of convertible debentures 2,735,349   1,353,364  
Fair value of debenture embedded conversion feature at date of issuance     (164,811)  
Relative fair value of warrants issued with convertible debentures 513,112 214,819 215,819   
ZQX Advisors LLC [Member]
        
Cash flows from financing activities:        
Proceeds from sale of common stock    24,138 24,138   
Proceeds from exercise of warrants to purchase common stock     381,000  
Stock Issued Upon Conversion Of Debenture [Member]
        
Supplemental disclosure of non-cash financing activities:        
Common stock issued upon conversion of convertible debentures 2,735,349 1,353,364 1,075,000   
Debenture Conversion Feature [Member]
        
Supplemental disclosure of non-cash financing activities:        
Fair value of debenture embedded conversion feature at date of issuance $ 1,570,000 $ 1,180,000 $ 1,180,000